Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1
Unknown1
Enrolling By Invitation1
Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07150221Enrolling By Invitation

MDR Vivacit-E Elevated Study

NCT05980234Terminated

MDR - Longevity IT Oblique and Offset Liners

NCT04117841RecruitingPrimary

SCFE Longitudinal International Prospective Registry

NCT03326531UnknownPrimary

"Gait and Balance in Patients With SCFE"

Showing all 4 trials

Research Network

Activity Timeline